Global Biotech Investment Firm Launches Backed By Woodford, Industry Vets
This article was originally published in Scrip
Executive Summary
What happens when an ex-Abingworth investment partner, former Amgen chief financial officer and Sir Chris, biotech tycoon, get together in a room? A new investment firm is born.